Scientech Research’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Scientech Research's RGEN Position: Q3 2025 in Review
Scientech Research sold out of Repligen (RGEN) in Q3 2025, closing a stake of 2,952 shares — an estimated $367K sold.
Scientech Research first reported a position in RGEN in Q1 2025 and held it in 2 quarters. The position peaked at $1.84M in Q1 2025. 456 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Scientech Research reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Scientech Research sold 2,952 Repligen shares in Q3 2025, an estimated $367K.
- Scientech Research first reported a position in Repligen in Q1 2025 and held it in 2 quarters.
- Scientech Research's Repligen position peaked at $1.84M in Q1 2025.
- 456 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Scientech Research's 13F filing for Q3 2025, filed 14 Nov 2025.